Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 53 min ago
PreprintAll rights reservedbioRxiv

BNCT Triggers Immunogenic Cell Death in B16 Melanoma Without Accompanying T-Cell Infiltration--Implications for Combination Immunotherapy

  • R. Quan
  • H. Huang
  • L. Zhang
  • C. Zhang
  • S. Chang
  • M. Wu
  • S. Zhang
  • L. Zhang
  • Z. Dai
  • L. Gu1
  1. 1Frontiers Science Center for Rare Isotopes, Lanzhou University, Lanzhou, China.
Read full textPDFDOICite

Related

  1. Interpretable CT-Based Radiomics for Prediction of High-Affinity Neoantigens Associated Immunogenic States in Advanced Hepatocellular Carcinoma Treated with TACE Plus Targeted Therapy and Immunotherapy.
    Chaofan Bian, Yanjin Qin, Hongliang Zou +2
    CancersPeer-reviewedCC BYFull textMedical imaging & radiologyEurope PMCCrossref
  2. An immunogenic cell death-related classification for prognostic stratification and immunotherapy response prediction in proficient mismatch repair/microsatellite stable colorectal cancer.
    Jia He, Jinxiu Qu, Yuan Zhao +5
    Journal of gastrointestinal oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  3. Efficacy and safety of narlumosbart in combination with stereotactic body radiation therapy followed by first-line chemotherapy combined with immunotherapy in advanced driver gene-negative non-small cell lung cancer patients with bone metastases: a phase II, single-arm, single-centre clinical trial protocol
    Jin Li, Nianlan Zhou, Saiquan Lu +4
    BMJ OpenPeer-reviewedCC BY-NC 4.0Full textGeneral medicineCrossref
  4. 1189 A phase 1/1b study of the tumor-activated IL-2 prodrug WTX-124 alone or in combination with pembrolizumab in adults with relapsed/refractory, advanced/metastatic, immunotherapy-sensitive solid tumors
    Justin Moser, Igor Puzanov, Hans Hammers +15
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  5. Combination of antibody–drug conjugates with immunotherapy: a new paradigm in cancer treatment
    Yongli Lai, Ruyu Qin, Zhaidong Liu
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC

Cite

BibTeXRIS
BibTeX
@misc{quan2026bnct,
  title = {{BNCT Triggers Immunogenic Cell Death in B16 Melanoma Without Accompanying T-Cell Infiltration--Implications for Combination Immunotherapy}},
  author = {R. Quan and H. Huang and L. Zhang and C. Zhang and S. Chang and M. Wu and S. Zhang and L. Zhang and Z. Dai and L. Gu},
  howpublished = {bioRxiv},
  year = {2026},
  month = nov,
  doi = {10.64898/2026.11.04.764456},
  url = {https://www.biorxiv.org/content/10.64898/2026.11.04.764456v1},
}
RIS
TY  - UNPB
TI  - BNCT Triggers Immunogenic Cell Death in B16 Melanoma Without Accompanying T-Cell Infiltration--Implications for Combination Immunotherapy
AU  - R. Quan
AU  - H. Huang
AU  - L. Zhang
AU  - C. Zhang
AU  - S. Chang
AU  - M. Wu
AU  - S. Zhang
AU  - L. Zhang
AU  - Z. Dai
AU  - L. Gu
PY  - 2026
DA  - 2026/11/04
PB  - bioRxiv
DO  - 10.64898/2026.11.04.764456
UR  - https://www.biorxiv.org/content/10.64898/2026.11.04.764456v1
ER  -